Fig. 4From: Green synchronous spectrofluorimetric analysis of remdesivir, the first approved antiviral, with levodropropizine as add-on therapy for covid-19: application in their pharmaceutical dosage form, and spiked human plasmaSynchronous fluorescence spectra of remdesivir and levodropropizine using Δλ = 130 nmBack to article page